Gary Potter

Dr. Gary Potter

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2013 in Journal of Drug Issues
Verified
Journal Article
Closed access
PDF file
MTMatthew Taylor
Matthew Taylor
GPGary Potter
Gary Potter
This article reports on an empirical study into a group of drug dealers supplying cannabis, ecstasy, cocaine, ketamine, and other drugs in and around a small English city. It reveals a market that is not overly structured or hierarchically controlled, and certainly not dominated by organized crime or characterized by violence. Dealers involved had often drifted into “real” dealing from backgrounds in “social supply.” However, despite an increase of their dealing activity (and of their profits), they still maintained the “social supply” values of friendship and trust as the key elements to relationships with suppliers and customers. Escalation of drug dealing did not seem to be accompanied by any wider escalation in criminality or involvement with organized crime.

1 March 2015 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MBMonica J. Barratt
Monica J. Barratt
GPGary Potter
Gary Potter
MWMarije Wouters
Marije Wouters
CWChris Wilkins
Chris Wilkins
BWBernd Werse
Bernd Werse
TBThomas Blok
Thomas Blok

1 March 2015 in International Journal of Drug Policy
Verified
Journal Article
Closed access
GPGary Potter
Gary Potter
MBMonica J. Barratt
Monica J. Barratt
AMAili Malm
Aili Malm
MBMartin Bouchard
Martin Bouchard
TBThomas Blok
Thomas Blok
MWMarije Wouters
Marije Wouters

1 March 2015 in International Journal of Drug Policy
Verified
Journal Article
Closed access
PHPekka Hakkarainen
Pekka Hakkarainen
VFVibeke Asmussen Frank
Vibeke Asmussen Frank
MBMonica J. Barratt
Monica J. Barratt
HDHelle Vibeke Dahl
Helle Vibeke Dahl
TDTom Decorte
Tom Decorte
BWBernd Werse
Bernd Werse

1 January 2019 in Methodological Innovations
Verified
Journal Article
Open access
PDF file
TDTom Decorte
Tom Decorte
AMAili Malm
Aili Malm
SSSharon R Sznitman
Sharon R Sznitman
PHPekka Hakkarainen
Pekka Hakkarainen
MBMonica J Barratt
Monica J Barratt
VFVibeke Asmussen Frank
Vibeke Asmussen Frank
It is common practice in survey questionnaires to include a general open and non-directive feedback question at the end, but the analysis of this type of data is rarely discussed in the methodological literature. While these open-ended comments can be useful, most researchers fail to report on this issue. The aim of this article is to illustrate and reflect upon the benefits and challenges of analyzing responses to open-ended feedback questions. The article describes the experiences of coding and analyzing data generated through a feedback question at the end of an international online survey with small-scale cannabis cultivators carried out by the Global Cannabis Cultivation Research Consortium. After describing the design and dataset of the web survey, the analytical approach and coding frame are presented. The analytical strategies chosen in this study illustrate the diversity and complexity of feedback comments which pose methodological challenges to researchers wishing to use them for data analyses. In this article, three types of feedback comments (political/policy comments, general comments of positive and negative appreciation, and methodological comments) are used to illustrate the difficulties and advantages of analyzing this type of data. The advantages of analyzing feedback comments are well known, but they seem to be rarely exploited. General feedback questions at the end of surveys are typically non-directive. If researchers want to use these data for research and analyses, they need a clear strategy. They ought to give enough thought to why they are including this type of question, and develop an analytical strategy at the design stage of the study.

31 August 2020 in Contemporary Drug Problems
Verified
Journal Article
Open access
PDF file
ARAnna Ross
Anna Ross
GPGary Potter
Gary Potter
MBMonica J. Barratt
Monica J. Barratt
JAJudith A. Aldridge
Judith A. Aldridge
Some personal experience of illicit drug use undoubtedly exists within the population of academic drug researchers. But it is rarely acknowledged, and even more rarely reflected upon, in their published work. This is understandable: criminal, professional and social sanctions may follow public admission of illicit activities. However, to not “come out” seems contrary to some core academic principles, such as transparency in data collection and reflexivity in the research process. Coming out may present researchers with an opportunity for improving knowledge of, and policies toward, drug use. In this article, we identify reasons for and against the public disclosure of drug use and the impact of such disclosure across a range of spheres, including research, teaching, policy influence and private lives. Reasons against coming out include the risks of undermining professional reputations and hence the ability to contribute to academic and policy debates, the threat of criminal justice sanctions, and impacts on loved ones. However, coming out can have academic benefit (i.e., improving our understanding of drugs, of people who use drugs, and of drug research) and contribute to activist goals (e.g., de-stigmatization of drug use and demarginalization of people who use drugs). Both the risks and benefits of public drug use disclosure have implications for how research and researchers may influence drug policy. Two key themes, stigma and reflexivity, underpin the discussion. We do not conclude with clear recommendations for drug-using drug researchers; to come out or to not come out is a personal decision. However, we argue that there is clear merit to further open discussion on the role of disclosure and reflection on personal drug use experience among those working in drug research and drug policy—where such reflection is relevant and where such researchers feel able to do so.